Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Rodriguez-Viciana

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Science (New York, N.Y.)|January 28, 2006
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndromePablo Rodriguez-Viciana, Osamu Tetsu, William E Tidyman, et al.
Cancer Research|October 3, 2008
PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformationKatsutoshi Oda, Jennifer Okada, Luika Timmerman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2018
SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesisLucy C Young, Nicole Hartig, Isabel Boned Del Río, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamicsIsabel Boned Del Río, Lucy C Young, Sibel Sari, et al.
Nature Structural & Molecular Biology|September 29, 2022
Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndromeDaniel A Bonsor, Patrick Alexander, Kelly Snead, et al.
Nature Communications|June 12, 2019
SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancersGreg G Jones, Isabel Boned Del Río, Sibel Sari, et al.
Molecular Cell|November 12, 2013
An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growthLucy C Young, Nicole Hartig, Marta Muñoz-Alegre, et al.
Plos One|August 23, 2021
Cell-cell adhesion regulates Merlin/NF2 interaction with the PAF complexAnne E Roehrig, Kristina Klupsch, Juan A Oses-Prieto, et al.
EMBO Molecular Medicine|May 18, 2013
ERBB4 confers metastatic capacity in Ewing sarcomaAriadna Mendoza-Naranjo, Amal El-Naggar, Daniel H Wai, et al.
American Journal of Medical Genetics. Part A|December 12, 2019
The sixth international RASopathies symposium: Precision medicine-From promise to practiceKaren W Gripp, Lisa Schill, Lisa Schoyer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Science (New York, N.Y.)|January 28, 2006
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndromePablo Rodriguez-Viciana, Osamu Tetsu, William E Tidyman, et al.
Cancer Research|October 3, 2008
PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformationKatsutoshi Oda, Jennifer Okada, Luika Timmerman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2018
SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesisLucy C Young, Nicole Hartig, Isabel Boned Del Río, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamicsIsabel Boned Del Río, Lucy C Young, Sibel Sari, et al.
Nature Structural & Molecular Biology|September 29, 2022
Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndromeDaniel A Bonsor, Patrick Alexander, Kelly Snead, et al.
Nature Communications|June 12, 2019
SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancersGreg G Jones, Isabel Boned Del Río, Sibel Sari, et al.
Molecular Cell|November 12, 2013
An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growthLucy C Young, Nicole Hartig, Marta Muñoz-Alegre, et al.
Plos One|August 23, 2021
Cell-cell adhesion regulates Merlin/NF2 interaction with the PAF complexAnne E Roehrig, Kristina Klupsch, Juan A Oses-Prieto, et al.
EMBO Molecular Medicine|May 18, 2013
ERBB4 confers metastatic capacity in Ewing sarcomaAriadna Mendoza-Naranjo, Amal El-Naggar, Daniel H Wai, et al.
American Journal of Medical Genetics. Part A|December 12, 2019
The sixth international RASopathies symposium: Precision medicine-From promise to practiceKaren W Gripp, Lisa Schill, Lisa Schoyer, et al.
Pageof 2